SARS-CoV-2, a new causative agent of Guillain-Barré syndrome?

Esteban Molina, A; Mata Martínez, M; Sánchez Chueca, P; Carrillo López, A

Esteban Molina, A; Mata Martínez, M; Sánchez Chueca, P; Carrillo López, A.

Esteban Molina A; Servicio de Medicina Intensiva, Hospital Universitario Miguel Servet, Zaragoza, Spain. Electronic address: a.estebanmolina@hotmail.com.
Mata Martínez M; Servicio de Medicina Intensiva, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Sánchez Chueca P; Servicio de Medicina Intensiva, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Carrillo López A; Servicio de Medicina Intensiva, Hospital Universitario Miguel Servet, Zaragoza, Spain.

Med Intensiva (Engl Ed) ; 46(2): 110-111, 2022 02.

Article in English | MEDLINE | ID: covidwho-1670889

Subject(s)

COVID-19; Guillain-Barre Syndrome; Guillain-Barre Syndrome/diagnosis; Guillain-Barre Syndrome/etiology; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Med Intensiva (Engl Ed) Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google